DocMorris AGXSWX:DOCM +1.84%65 Cyclically Adjusted PS Ratio is 0.10 as of Jun. 28, 2026, which is 76% below its 10-year median of 0.42. GuruFocus rates XSWX:DOCM with a GF Score™ of 65/100 and a GF Value™ of CHF10.53 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 356 Healthcare Providers & Services companies, DocMorris AG ranks better than 95.79% on this metric.
The historical rank and industry rank for DocMorris AG's Cyclically Adjusted PS Ratio or its related term are showing as below:
XSWX:DOCM'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.05 Med: 0.42 Max: 2.56
Current: 0.1
During the past 13 years, DocMorris AG's highest Cyclically Adjusted PS Ratio was 2.56. The lowest was 0.05. And the median was 0.42.
XSWX:DOCM's Cyclically Adjusted PS Ratio is ranked better than 95.79% of 356
companies
in the Healthcare Providers & Services industry
Industry Median: 1.145
vs XSWX:DOCM: 0.10
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
DocMorris AG's adjusted revenue per share data of for the fiscal year that ended in Dec24 was CHF42.467. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is CHF81.92 for the trailing ten years ended in Dec24.
Shiller PE for Stocks: The True Measure of Stock Valuation
DocMorris AG (XSWX:DOCM) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
DocMorris AG Cyclically Adjusted PS Ratio Related Terms
DocMorris AG Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for DocMorris AG's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG Cyclically Adjusted PS Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, DocMorris AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where DocMorris AG's Cyclically Adjusted PS Ratio falls into.
DocMorris AG Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
DocMorris AG's Cyclically Adjusted PS Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 0.10 mean?
DocMorris AG (XSWX:DOCM) has a Cyclically Adjusted PS Ratio of 0.10 as of Jun. 28, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on DocMorris AG and its competitors. This is 76% below median its historical median of 0.42. Over the past decade, DocMorris AG's Cyclically Adjusted PS Ratio has ranged from 0.05 to 2.56. According to the industry distribution chart, DocMorris AG ranks #15 out of 356 companies in the Healthcare Providers & Services industry, placing it in the top 4.2%.
Is DocMorris AG's Cyclically Adjusted PS Ratio too high?
DocMorris AG's current Cyclically Adjusted PS Ratio of 0.10 is 76% below median its 10-year median of 0.42. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 2.56. The Healthcare Providers & Services industry median Cyclically Adjusted PS Ratio is 1.15. DocMorris AG's value of 0.10 is 91.3% below this industry median. Based on the distribution chart, DocMorris AG ranks #15 out of 356 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Cyclically Adjusted PS Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #15 out of 356 companies for Cyclically Adjusted PS Ratio. This places DocMorris AG in the top 4% of its industry — outperforming the majority of peers. The industry median Cyclically Adjusted PS Ratio is 1.15. DocMorris AG's value of 0.10 is 91.3% below this benchmark. Historically, DocMorris AG's own Cyclically Adjusted PS Ratio has ranged from 0.05 to 2.56 over the past decade. While the company's 10-year median is 0.42 vs. the industry median of 1.15, DocMorris AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Healthcare Providers & Services company?
The median Cyclically Adjusted PS Ratio among Healthcare Providers & Services companies is 1.15, based on 356 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocMorris AG's current Cyclically Adjusted PS Ratio of 0.10 is 91.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on DocMorris AG and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted PS Ratio is 1.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current Cyclically Adjusted PS Ratio is 0.10, which is 76% below median its own 10-year median of 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.53, compared to a current price of CHF8.30 — trading 21.2% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.10, which is 76% below median its 10-year median of 0.42 and 91.3% below the Healthcare Providers & Services industry median of 1.15. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current Cyclically Adjusted PS Ratio is 0.10 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF8.30 is trading 21.2% below its estimated GF Value™ of CHF10.53.
GuruFocus considers DocMorris AG to be Modestly Undervalued.
Key valuation signals for XSWX:DOCM:
Cyclically Adjusted PS Ratio: 0.10 (76% below median its 10-year median of 0.42)
GF Value™: CHF10.53 vs. price of CHF8.30 (21.2% below fair value)
Industry Position: 91.3% below the Healthcare Providers & Services median (#15 of 356)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 
